Scpharmaceuticals
Price & Volume
Stats
See more52W Range | $1.94-$5.65 |
Market Cap | $126.2M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $36.3M |
Revenue Growth (YoY) | 99.3% |
Gross Profit (12 Mos) | $24.9M |
Diluted EPS | -$1.91 |
News
See moreYahoo Finance • last month
scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Yahoo Finance • last month
scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025
Yahoo Finance • 2 months ago
scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease
Yahoo Finance • 3 months ago
scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
About
CEO | Mr. John H. Tucker |
Address | 25 Mall Road, Burlington, MA, United States, 01803 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 162 |
